(Q47763532)

5 February 2018

title

Granulocyte colony-stimulating factor in the combination chemotherapy for adult T-cell leukemia (ATL). (English)

1 reference

5 February 2018

1 reference

1 reference

1 reference

Uozumi K

1

1 reference

5 February 2018

Nakahara K

2

1 reference

5 February 2018

Takatsuka Y

3

1 reference

5 February 2018

Ohno N

4

1 reference

5 February 2018

Makino T

5

1 reference

5 February 2018

Utsunomiya A

6

1 reference

5 February 2018

Hanada S

7

1 reference

5 February 2018

Arima T

8

1 reference

5 February 2018

publication date

1 April 1998

1 reference

5 February 2018

published in

Leukemia & Lymphoma

1 reference

5 February 2018

volume

29

1 reference

5 February 2018

issue

3-4

1 reference

5 February 2018

page(s)

407-414

1 reference

5 February 2018

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Comparison of CHOP versus VEPA Therapy in Patients with Lymphoma Type of Adult T-cell Leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

2'-Deoxycoformycin therapy in adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

Infectious complications and immunodeficiency in patients with human T-cell lymphotropic virus I-associated adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809068577

10.3109/10428199809068577

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018